EBOLA vaccinations that were trialled in Oxford are now being given to people under threat in Africa.

A hospital in Dakar, Senegal, has started immunising patients from the virus, which has killed more than 11,000 people on the African continent.

The two vaccines being used in the clinical trial were tested on human subjects at Oxford University’s Jenner Institute last year.

The first vaccination helps produce an initial immune response to the disease, and the second vaccine helps the body to continue fighting the disease.

Although the spread of the disease has decreased, between June 29 and July 5 there were 30 confirmed cases of Ebola in West Africa.

Jenner Institute director Professor Adrian Hill added: “When you consider that Ebola affects some of the world’s poorer countries and can spread rapidly, getting the scale of manufacturing up while keeping the cost down is key to delivering an effective response.”

The Jenner Institute is still testing the drug on human subjects in the UK, as well as Senegal.